Cilo Cybin CEO Gabriel Theron says while some may "laugh" at the group's small size relative to the JSE at first, it's eyeing growth and perhaps even a US listing.
Now that it's secured a date for its listing on AltX, Cilo Cybin Holdings is setting its sights on significant future growth through new acquisitions in the biotech and medical cannabis sectors over the short term. Speaking to News24 in an interview on Friday, CEO and founder Gabriel Theron said some people may"laugh" at the initially small R70 million market capitalisation of Cilo Cybin when it joins the bourse on 25 June as a special purpose acquisition vehicle .
But the bigger picture is about the growth opportunities that come with listing. After its first initial acquisition, the group plans to graduate to the main board and then look to acquisitions of other branded products and distribution businesses, both locally and offshore.South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we're about to enter a new chapter of fearless journalism.